Measuring Cortisol Levels in Persons With Parkinson's (PD) (CORT-PD)

  • STATUS
    Recruiting
  • End date
    Dec 31, 2022
  • participants needed
    220
  • sponsor
    Oregon Health and Science University
Updated on 9 May 2022
parkinson's disease
huntington's disease
movement disorder
chorea
nervous system disorder
Accepts healthy volunteers

Summary

The objective of this study is to evaluate the cortisol awakening response with persons with Parkinsons Disease (PD), Huntingtons Disease (HD), and controls. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD, HD, and controls.

Description

Telephone consent will be obtained.

Participants will collect saliva at twelve time points - four times a day for three days.

Visits will be conducted virtually (over the internet).

The virtual visit is to assess Parkinson's or Huntington's disease status, stress, mood, and quality of life.

Details
Condition Parkinson Disease, Huntington Disease
Treatment No Intervention - Observational Study
Clinical Study IdentifierNCT02727270
SponsorOregon Health and Science University
Last Modified on9 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Group (1) Inclusion
PD as confirmed by NINDS criteria
PD confirmed by a movement disorders specialist
a Perceived Stress Scale (PSS) score higher than or equal to 13
Group (2) Inclusion
PD as confirmed by NINDS criteria
PD confirmed by a movement disorders specialist
PSS score lower than 13
Group (3) Inclusion
No significant neurological disorder
PSS score of greater than or equal to 13
Group (4) Inclusion
No significant neurological disorder
PSS score of less than 13
Group (5) Inclusion
HD diagnosis
HD confirmed by a movement disorders specialist
a Perceived Stress Scale (PSS) score higher than or equal to 13
Group (6) Inclusion
HD diagnosis
HD confirmed by a movement disorders specialist
PSS score lower than 13
Group (7) Inclusion
Completion of the study prior to COVID-19 Restrictions in March of 2020

Exclusion Criteria

The use of medications known to effect cortisol levels (estrogen, synthetic glucocorticoids, androgens, phenytoin, spironolactone, prednisone, prednisolone, and hydrocortisone)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note